Barinthus Biotherapeutics plc (NASDAQ: BRNS)
$1.0750
+0.0550 ( +2.38% ) 12.3K
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
Market Data
Open
$1.0750
Previous close
$1.0200
Volume
12.3K
Market cap
$43.13M
Day range
$0.9860 - $1.1050
52 week range
$0.8008 - $4.1591
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 3 | Insider transactions | 2 | Dec 20, 2024 |
| 8-k | 8K-related | 16 | Nov 25, 2024 |
| 8-k | 8K-related | 49 | Nov 15, 2024 |
| 8-k | 8K-related | 16 | Nov 06, 2024 |
| 10-q | Quarterly Reports | 78 | Nov 06, 2024 |
| 8-k | 8K-related | 14 | Sep 05, 2024 |
| 8-k | 8K-related | 17 | Aug 08, 2024 |
| 10-q | Quarterly Reports | 75 | Aug 08, 2024 |
| 3 | Insider transactions | 2 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 18, 2024 |